LEIDOS BIOMEDICAL RESEARCH INC

Federal contract award, Leidos, $9,229,699

Key CONT_AWD_75N91018F00057_7529_HHSN261201500003I_7529. First seen by this system September 5, 2026 through the historical sweep, new to the watchlist, public 137 days before this system saw it. One version on record.

Cite this row

On this site https://evidence.ourrevolution.media/filings/leidos/CONT_AWD_75N91018F00057_7529_HHSN261201500003I_7529

At the source https://www.usaspending.gov/award/CONT_AWD_75N91018F00057_7529_HHSN261201500003I_7529

Observed 2026-09-05, version 1, retrieved 2026-09-05T00:55:09Z

Content hash 7d4981cb6de9176b7c8c0db512fa38faf4ee675fa1ef37b0b94e2b61995cfe6d

The source record can change after this date; the key, hash and retrieval time name exactly the response this system stored. See license and citation.

Versions

Version	Amount	Change	Occurred	Published	Retrieved	How it arrived	Content hash
1 current	$9,229,699	first version	July 13, 2018	April 21, 2026	2026-09-05T00:55:09Z	historical sweep	`7d4981cb6de9`

Archived copy

https://web.archive.org/web/20261013051530/https://www.usaspending.gov/award/CONT_AWD_75N91018F00057_7529_HHSN261201500003I_7529 captured by this system, October 13, 2026

What the amount is made of

7 recorded actions, so the amount is the award's current total across all of them. 4 of them obligated money. Measured 2026-10-11, when USAspending reported a total obligation of $9,229,699.

Action date	Modification	Type	Obligated	Description as recorded
September 17, 2025	P00006	FUNDING ONLY ACTION	+$23,199	FY26 UDO INITIATIVE - ANTI-HIV BROADLY NEUTRALIZING MONOCLONAL ANTIBODY (BNABS) DRUG SUBSTANCE (DS) CLINICAL TRIAL MATERIAL PRODUCTION AND RELEASE
March 8, 2022	P00005	OTHER ADMINISTRATIVE ACTION	no money	ANTI-HIV BROADLY NEUTRALIZING MONOCLONAL ANTIBODY (BNABS) DRUG SUBSTANCE (DS) CLINICAL TRIAL MATERIAL PRODUCTION AND RELEASE
June 14, 2021	P00004	OTHER ADMINISTRATIVE ACTION	no money	ANTI-HIV BROADLY NEUTRALIZING MONOCLONAL ANTIBODY (BNABS) DRUG SUBSTANCE (DS) CLINICAL TRIAL MATERIAL PRODUCTION AND RELEASE
November 10, 2020	P00003	SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE	+$192,653	ANTI-HIV BROADLY NEUTRALIZING MONOCLONAL ANTIBODY (BNABS) DRUG SUBSTANCE (DS) CLINICAL TRIAL MATERIAL PRODUCTION AND RELEASE
July 27, 2020	P00002	SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE	no money	ANTI-HIV BROADLY NEUTRALIZING MONOCLONAL ANTIBODY (BNABS) DRUG SUBSTANCE (DS) CLINICAL TRIAL MATERIAL PRODUCTION AND RELEASE
September 23, 2019	P00001	CHANGE ORDER	+$1,594,108	ANTI-HIV BROADLY NEUTRALIZING MONOCLONAL ANTIBODY (BNABS) DRUG SUBSTANCE (DS) CLINICAL TRIAL MATERIAL PRODUCTION AND RELEASE
July 13, 2018	base	not on file	+$7,419,739	IGF::OT::IGF ANTI-HIV BROADLY NEUTRALIZING MONOCLONAL ANTIBODY (BNABS) DRUG SUBSTANCE (DS) CLINICAL TRIAL MATERIAL PRODUCTION AND RELEASE

Last refreshed November 4, 2026 at 2:31 PM UTC.